We support clients to develop a clear regulatory strategy enabling them to develop their drugs as efficiently as possible. We have experience across a range of drug types including small molecules, biologics and drug-device combinations. We understand the specific regulatory requirements in the US, Europe and Japan enabling us to support our clients ranging from biotech start-ups to mid-sized pharmaceutical companies.